On December 23, 2025, Sen. Rand Paul (R-Ky.) released his annual Festivus report, which cites a total of $1.6 trillion in unnecessary federal spending, including $1.22 trillion in interest payments on the national debt. The report cites $77 million for Department of Defense (DOD)’s outdated Marine Mammal Program, which trains dolphins and sea lions to […]
This Week in Waste – October 31, 2025
Welcome to This Week in Waste, a series by Citizens Against Government Waste (CAGW) that highlights how taxpayer dollars are being wasted in the federal, state, and local levels of government and efforts to fight back against this spendthrift behavior. Senate Health, Education, Labor, and Pensions (HELP) Committee Hearing is Next Step for 340B Reform The […]
Price Controls Are Always a Bad Idea
Prices controls have always disrupted the marketplace and created shortages or excesses.
The Human Cost of Pharmaceutical Price Controls is Too High
Price controls will result in the loss of life due to a lack of future research and development.
The Senate Should Not Implement Price Controls on Pharmaceuticals
Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
The Resurgence of the Build Back Better Act is Inevitable
The BBBA is more big government socialism, with a price tag of $4.9 trillion over 10 years.
Price Controls Will Create an Invisible Graveyard of Americans
The Build Back Better Act will cost lives by devastating the development of future cures.
Obamacare Survives Third Court Challenge
The Supreme Court tossed out ObamaCare lawsuit, California et al v. Texas, stating the plaintiffs have no standing.
Lack of Trust in Public Health Authorities Will Impact Debate on Medicare for All
The U.S. public health system has a trust problem due to their handling of COVID-19.
Big Pharma DOES Negotiate Drug Prices
On March 7, 2017, President Trump tweeted he was “working on a new system where there will be competition in the Drug Industry. Pricing for the American people will come way down.” The next day, in a meeting with Representatives Elijah Cummings (D-Md.) and Peter Welch (D-Vt.) , the president reiterated that he wanted to […]





